Hyperplasia of prostate. Enlarged prostate
Conditions
Interventions
Intervention 1: In the control group, 25 mg Pethidine ampoule every 8 hours and a placebo pill will be prescribed daily. Intervention 2: In the intervention group, in addition to 25 mg Pethidine ampou
Sponsors
Ghoum University of Medical Sciences
Eligibility
Sex/Gender
Male
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: Patients who have undergone prostate urethral resection surgery Not having coagulation disorders Not having an allergy to curcumin Not having drug addiction
Exclusion criteria
Exclusion criteria: Abnormal bleeding after surgery (more than 300 cc) Criticality of the patient's vital signs
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Pain. Timepoint: Immediately before the intervention and every 6 hours after the intervention until discharge. Method of measurement: Visual Analogue Scale. | — |
Secondary
| Measure | Time frame |
|---|---|
| Blood pressure. Timepoint: Immediately before the intervention and every 6 hours after the intervention until discharge. Method of measurement: Vital Sign Monitoring Device.;Blood coagulation tests. Timepoint: Immediately before the intervention and every 24 hours after the intervention until discharge. Method of measurement: Using PT, PTT, INR laboratory tests. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactAtye Babaii
Ghoum University of Medical Sciences
Outcome results
None listed